These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28757704)

  • 1. Retinopathy in hepatitis C.
    Sriwijitalai W; Wiwanitkit V
    Oman J Ophthalmol; 2017; 10(2):124. PubMed ID: 28757704
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C: a review of diagnosis, management, and ocular complications from treatment.
    Tsolakos A; Zalatimo N
    Optometry; 2003 Aug; 74(8):517-23. PubMed ID: 12926825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of hepatitis C virus-associated retinopathy.
    Abe T; Nakajima A; Satoh N; Koizumi T; Sakuragi S; Ono T; Komatsu M; Masamune O
    Jpn J Ophthalmol; 1995; 39(4):411-9. PubMed ID: 8926649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-associated retinopathy during the treatment of chronic hepatitis C: a systematic review.
    Raza A; Mittal S; Sood GK
    J Viral Hepat; 2013 Sep; 20(9):593-9. PubMed ID: 23910642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is screening for interferon retinopathy in hepatitis C justified?
    Cuthbertson FM; Davies M; McKibbin M
    Br J Ophthalmol; 2004 Dec; 88(12):1518-20. PubMed ID: 15548803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin.
    Fouad YM; Khalaf H; Ibraheem H; Rady H; Helmy AK
    Int J Infect Dis; 2012 Jan; 16(1):e67-71. PubMed ID: 22115957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C and interferon-associated retinopathy: a case report.
    Van Wie AM
    Optometry; 2011 Dec; 82(12):739-43. PubMed ID: 22108545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon alfa.
    Hayasaka S; Fujii M; Yamamoto Y; Noda S; Kurome H; Sasaki M
    Br J Ophthalmol; 1995 Feb; 79(2):150-2. PubMed ID: 7696235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinopathy and Uveitis Associated with Sofosbuvir Therapy for Chronic Hepatitis C Infection.
    Chin-Loy K; Galaydh F; Shaikh S
    Cureus; 2016 May; 8(5):e597. PubMed ID: 27335709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C.
    Okuse C; Yotsuyanagi H; Nagase Y; Kobayashi Y; Yasuda K; Koike K; Iino S; Suzuki M; Itoh F
    World J Gastroenterol; 2006 Jun; 12(23):3756-9. PubMed ID: 16773695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of risk factors of interferon-associated retinopathy in patients with type C chronic active hepatitis].
    Soushi S; Kobayashi F; Obazawa H; Kigasawa K; Shiraishi K; Itakura M; Matsuzaki S
    Nippon Ganka Gakkai Zasshi; 1996 Jan; 100(1):69-76. PubMed ID: 8644532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interferon dysoric retinopathy in chronic viral hepatitis C: case report and literature review].
    Naïja N; Mohsni B; Belkahla N; Maamouri N; Ben Mami N
    Rev Med Interne; 2014 Aug; 35(8):543-5. PubMed ID: 24182682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal circulatory changes associated with interferon-induced retinopathy in patients with hepatitis C.
    Nagaoka T; Sato E; Takahashi A; Yokohama S; Yoshida A
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):368-75. PubMed ID: 17197556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of retinopathy in chronic hepatitis C patients treated with pegylated interferon alpha 2a and ribavirin combination therapy.
    Kashif M; Saleem MK; Farooka IK; Husnain A; Siddiqui AM
    Pak J Med Sci; 2015; 31(1):174-7. PubMed ID: 25878638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pegylated interferon-associated retinopathy is frequent in hepatitis C virus patients with hypertension and justifies ophthalmologic screening.
    Vujosevic S; Tempesta D; Noventa F; Midena E; Sebastiani G
    Hepatology; 2012 Aug; 56(2):455-63. PubMed ID: 22331668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-associated retinopathy in a uniform regimen of natural interferon-alpha therapy for chronic hepatitis C.
    Saito H; Ebinuma H; Nagata H; Inagaki Y; Saito Y; Wakabayashi K; Takagi T; Nakamura M; Katsura H; Oguchi Y; Ishii H
    Liver; 2001 Jun; 21(3):192-7. PubMed ID: 11422782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinopathy associated with pegylated interferon and ribavirin treatment for chronic hepatitis C.
    Adams S; Ostermeier M
    Optometry; 2010 Nov; 81(11):580-6. PubMed ID: 20655283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retinopathy during interferon treatment in combination with ribavirin for chronic hepatitis C].
    Nakamura T; Takahashi H; Koike N; Mitsutaka M; Soda M; Kimu M
    Nippon Ganka Gakkai Zasshi; 2005 Nov; 109(11):748-52. PubMed ID: 16363669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual course of interferon-related retinopathy in chronic hepatitis C.
    Mathur G; Singh DV; Singal A
    Oman J Ophthalmol; 2016; 9(3):189-190. PubMed ID: 27843241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pegylated-interferon-associated retinopathy in chronic hepatitis patients.
    Lim JW; Shin MC
    Ophthalmologica; 2010; 224(4):224-9. PubMed ID: 19940529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.